Literature DB >> 17479308

Effect of tryptophan depletion on the attentional salience of smoking cues.

Brian Hitsman1, Bonnie Spring, Regina Pingitore, Marcus Munafò, Donald Hedeker.   

Abstract

RATIONALE: There is increasing evidence linking cigarette craving and smoking behavior to serotonergic neurotransmission.
OBJECTIVES: The purpose of the current study was to examine the effects of a serotonergic challenge on the attentional salience of various cues associated with cigarettes. We hypothesized that cigarette-related word cues would be more distracting after acute tryptophan depletion than after a placebo challenge. We also hypothesized that smokers vulnerable to recurrent depression would show greater attentional bias towards these cues than smokers without a history of depression.
METHODS: Thirty-four smokers diagnosed as having (n = 15) or lacking (n = 19) a history of DSM-IV major depressive disorder (MDD) underwent acute tryptophan depletion (ATD) and placebo challenges in double-blind and counterbalanced order 1 week apart. Five hours after consumption of each mixture, subjects completed a modified Stroop task to measure attentional bias to smoking-related, positive affect, and negative affect word cues. Stroop interference was calculated as a difference score between latencies for the motivationally salient and the neutral (furniture) word lists.
RESULTS: Controlling for change in dysphoric mood from baseline to 5 h, repeated measures MANOVAs showed that ATD, as compared to placebo challenge, produced greater interference for smoking word cues [F(1,29)=4.15, p = 0.05], but not for negative [F(1,29)=2.78, p = 0.11] or positive [F(1,29)=1.60, p = 0.22] affect word cues.
CONCLUSIONS: Acutely compromising central serotonergic neurotransmission via ATD heightens the attentional salience of cigarette-related cues, perhaps by triggering reward and motivational deficits underlying nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479308     DOI: 10.1007/s00213-007-0722-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  45 in total

1.  Effects of tryptophan depletion on acute smoking abstinence symptoms and the acute smoking response.

Authors:  Mary Perugini; Colleen Mahoney; Vadim Ilivitsky; Simon N Young; Verner Knott
Journal:  Pharmacol Biochem Behav       Date:  2003-02       Impact factor: 3.533

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 4.  Acute tryptophan depletion. Part I: rationale and methodology.

Authors:  Sean D Hood; Caroline J Bell; David J Nutt
Journal:  Aust N Z J Psychiatry       Date:  2005-07       Impact factor: 5.744

5.  Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism.

Authors:  D G LeMarquand; C Benkelfat; R O Pihl; R M Palmour; S N Young
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

Review 6.  Neurobiological similarities in depression and drug dependence: a self-medication hypothesis.

Authors:  A Markou; T R Kosten; G F Koob
Journal:  Neuropsychopharmacology       Date:  1998-03       Impact factor: 7.853

7.  History and symptoms of depression among smokers during a self-initiated quit attempt.

Authors:  R Niaura; D M Britt; B Borrelli; W G Shadel; D B Abrams; M G Goldstein
Journal:  Nicotine Tob Res       Date:  1999-09       Impact factor: 4.244

8.  Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls.

Authors:  Brian Hitsman; Bonnie Spring; William Wolf; Regina Pingitore; John W Crayton; Donald Hedeker
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

9.  A randomized trial of sertraline as a cessation aid for smokers with a history of major depression.

Authors:  Lirio S Covey; Alexander H Glassman; Fay Stetner; Sarah Rivelli; Kurt Stage
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

10.  Nicotine abstinence produces content-specific Stroop interference.

Authors:  T M Gross; M E Jarvik; M R Rosenblatt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more
  10 in total

1.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

Review 2.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour.

Authors:  Maria Angelica Ehara Watanabe; Sandra Odebrecht Vargas Nunes; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves De Lima; Maria Helena Pelegrinelli Fungaro
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

3.  Smoking cue reactivity in adult smokers with and without depression: a pilot study.

Authors:  Andrea H Weinberger; Sherry A McKee; Tony P George
Journal:  Am J Addict       Date:  2012 Mar-Apr

4.  Nicotine primes attention to competing affective stimuli in the context of salient alternatives.

Authors:  Gregory L Asgaard; David G Gilbert; Debra Malpass; Chihiro Sugai; Amber Dillon
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

5.  Influence of Altered Hormonal Status on Platelet 5-HT and MAO-B Activity in Cigarette Smokers.

Authors:  Pannuru Padmavathi; Vaddi Damodara Reddy; Kodidela Swarnalatha; Reddyvari Hymavathi; N Ch Varadacharyulu
Journal:  Indian J Clin Biochem       Date:  2014-02-11

Review 6.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

7.  Measuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scale.

Authors:  Brian Hitsman; Biing-Jiun Shen; Ronald A Cohen; Sandra B Morissette; David J Drobes; Bonnie Spring; Kristin Schneider; David E Evans; Suzy B Gulliver; Barbara W Kamholz; Lawrence H Price; Raymond Niaura
Journal:  Psychopharmacology (Berl)       Date:  2010-06-26       Impact factor: 4.530

Review 8.  Why are Antidepressant Drugs Effective Smoking Cessation Aids?

Authors:  Mohammed Shoaib; Yazead Buhidma
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Differential contributions of dopamine and serotonin to orbitofrontal cortex function in the marmoset.

Authors:  S C Walker; T W Robbins; A C Roberts
Journal:  Cereb Cortex       Date:  2008-08-22       Impact factor: 5.357

10.  Smoking as a product of gene-environment interaction.

Authors:  Kent W Nilsson; Lars Oreland; Robert Kronstrand; Jerzy Leppert
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.